1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 11-glutathionylhepoxilin a3 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (11-glutathionylhepoxilin a3) | Trials (11-glutathionylhepoxilin a3) | Recent Studies (post-2010) (11-glutathionylhepoxilin a3) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 13 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demin, PM; Pace-Asciak, CR; Wang, MM | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 11-glutathionylhepoxilin a3
| Article | Year |
|---|---|
Stereoselective actions of hepoxilins A3 and B3 and their cyclopropane analogs (HxdeltaA3 and HxdeltaB3) on bradykinin and PAF-evoked potentiation of vascular leakage in rat skin.
Topics: 8,11,14-Eicosatrienoic Acid; Administration, Cutaneous; Animals; Bradykinin; Capillary Permeability; Cyclopropanes; Drug Synergism; Male; Platelet Activating Factor; Rats; Rats, Wistar; Skin; Stereoisomerism | 1999 |